SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Erik D. Guetschow, Surinder Kumar, David B. Lombard, Robert T. Kennedy, Identification of sirtuin 5 inhibitors by ultrafast microchip electrophoresis using nanoliter volume samples, Analytical and Bioanalytical Chemistry, 2016, 408, 3, 721

    CrossRef

  2. 2
    Pawel Zerr, Katrin Palumbo-Zerr, Jingang Huang, Michal Tomcik, Barbora Sumova, Oliver Distler, Georg Schett, Jörg H W Distler, Sirt1 regulates canonical TGF-β signalling to control fibroblast activation and tissue fibrosis, Annals of the Rheumatic Diseases, 2016, 75, 1, 226

    CrossRef

  3. 3
    L Morató, M Ruiz, J Boada, N Y Calingasan, J Galino, C Guilera, M Jové, A Naudí, I Ferrer, R Pamplona, M Serrano, M Portero-Otín, M F Beal, S Fourcade, A Pujol, Activation of sirtuin 1 as therapy for the peroxisomal disease adrenoleukodystrophy, Cell Death and Differentiation, 2015, 22, 11, 1742

    CrossRef

  4. 4
    Celine E Riera, Andrew Dillin, Can aging be 'drugged'?, Nature Medicine, 2015, 21, 12, 1400

    CrossRef

  5. 5
    Ye Fang, Combining label-free cell phenotypic profiling with computational approaches for novel drug discovery, Expert Opinion on Drug Discovery, 2015, 10, 4, 331

    CrossRef

  6. 6
    Robert G. Britton, Christina Kovoor, Karen Brown, Direct molecular targets of resveratrol: identifying key interactions to unlock complex mechanisms, Annals of the New York Academy of Sciences, 2015, 1348, 1
  7. 7
    Yuting Wu, Xiaoming Meng, Cheng Huang, Jun Li, Emerging role of silent information regulator 1 (SIRT1) in hepatocellular carcinoma: a potential therapeutic target, Tumor Biology, 2015, 36, 6, 4063

    CrossRef

  8. 8
    Lara Gibellini, Elena Bianchini, Sara De Biasi, Milena Nasi, Andrea Cossarizza, Marcello Pinti, Natural Compounds Modulating Mitochondrial Functions, Evidence-Based Complementary and Alternative Medicine, 2015, 2015, 1

    CrossRef

  9. 9
    Marta Llarena, Fernando Andrade, Mounia Hasnaoui, María P. Portillo, Patricia Pérez-Matute, Jose M. Arbones-Mainar, Elizabeth Hijona, María Jesús Villanueva-Millán, Leixuri Aguirre, Christian Carpéné, Luis Aldámiz-Echevarría, Potential renoprotective effects of piceatannol in ameliorating the early-stage nephropathy associated with obesity in obese Zucker rats, Journal of Physiology and Biochemistry, 2015,

    CrossRef

  10. 10
    Anya Alayev, Sara Malka Berger, Marina K. Holz, Resveratrol as a novel treatment for diseases with mTOR pathway hyperactivation, Annals of the New York Academy of Sciences, 2015, 1348, 1
  11. 11
    Oliver G. Rössler, Daniel Glatzel, Gerald Thiel, Resveratrol upregulates Egr-1 expression and activity involving extracellular signal-regulated protein kinase and ternary complex factors, Experimental Cell Research, 2015, 332, 1, 116

    CrossRef

  12. 12
    Giulio Maria Pasinetti, Jun Wang, Lap Ho, Wei Zhao, Lauren Dubner, Roles of resveratrol and other grape-derived polyphenols in Alzheimer's disease prevention and treatment, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2015, 1852, 6, 1202

    CrossRef

  13. 13
    Hui Jing, Hening Lin, Sirtuins in Epigenetic Regulation, Chemical Reviews, 2015, 115, 6, 2350

    CrossRef

  14. 14
    Gaia Favero, Lorenzo Franceschetti, Luigi Fabrizio Rodella, Rita Rezzani, Sirtuins, aging, and cardiovascular risks, AGE, 2015, 37, 4

    CrossRef

  15. 15
    Sandeep Rana, Elizabeth C. Blowers, Amarnath Natarajan, Small Molecule Adenosine 5′-Monophosphate Activated Protein Kinase (AMPK) Modulators and Human Diseases, Journal of Medicinal Chemistry, 2015, 58, 1, 2

    CrossRef

  16. 16
    Rute Martins, Kathleen J. Dumas, Gordon J. Lithgow, Targeting FOXOs to slow aging, Molecular inhibitors in targeted therapy, 2015, 1, 1

    CrossRef

  17. 17
    Charles C. Caldwell, Jia Yao, Roberta Diaz Brinton, Targeting the Prodromal Stage of Alzheimer’s Disease: Bioenergetic and Mitochondrial Opportunities, Neurotherapeutics, 2015, 12, 1, 66

    CrossRef

  18. 18
    Flavie Strappazzon, Francesco Cecconi, The multifaceted mitochondrion: An attractive candidate for therapeutic strategies, Pharmacological Research, 2015, 99, 425

    CrossRef

  19. 19
    Dieter A. Kubli, Åsa B. Gustafsson, Unbreak My Heart: Targeting Mitochondrial Autophagy in Diabetic Cardiomyopathy, Antioxidants & Redox Signaling, 2015, 22, 17, 1527

    CrossRef

  20. 20
    Quaovi H. Sodji, James R. Kornacki, Milan Mrksich, Adegboyega K. Oyelere, Epigenetic Technological Applications, 2015,

    CrossRef

  21. 21
    Christian Meyners, Robert Wawrzinek, Andreas Krämer, Steffen Hinz, Pablo Wessig, Franz-Josef Meyer-Almes, A fluorescence lifetime-based binding assay for acetylpolyamine amidohydrolases from Pseudomonas aeruginosa using a [1,3]dioxolo[4,5-f][1,3]benzodioxole (DBD) ligand probe, Analytical and Bioanalytical Chemistry, 2014, 406, 20, 4889

    CrossRef

  22. 22
    Christian A. Olsen, An Update on Lysine Deacylases Targeting the Expanding “Acylome”, ChemMedChem, 2014, 9, 3
  23. You have free access to this content23
    M Kanabus, S J Heales, S Rahman, Development of pharmacological strategies for mitochondrial disorders, British Journal of Pharmacology, 2014, 171, 8
  24. 24
    Hongwei Si, Dongmin Liu, Dietary antiaging phytochemicals and mechanisms associated with prolonged survival, The Journal of Nutritional Biochemistry, 2014, 25, 6, 581

    CrossRef

  25. 25
    Anna Ferretta, Antonio Gaballo, Paola Tanzarella, Claudia Piccoli, Nazzareno Capitanio, Beatrice Nico, Tiziana Annese, Marco Di Paola, Claudia Dell'Aquila, Michele De Mari, Ermanno Ferranini, Vincenzo Bonifati, Consiglia Pacelli, Tiziana Cocco, Effect of resveratrol on mitochondrial function: Implications in parkin-associated familiar Parkinson's disease, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2014, 1842, 7, 902

    CrossRef

  26. 26
    Steven G Gray, Epigenetic-based immune intervention for rheumatic diseases, Epigenomics, 2014, 6, 2, 253

    CrossRef

  27. You have free access to this content27
    Susanne Rohrbach, Muhammad Aslam, Bernd Niemann, Rainer Schulz, Impact of caloric restriction on myocardial ischaemia/reperfusion injury and new therapeutic options to mimic its effects, British Journal of Pharmacology, 2014, 171, 12
  28. 28
    Ye Fang, Label-free drug discovery, Frontiers in Pharmacology, 2014, 5,

    CrossRef

  29. 29
    Chunzi Liang, Benjamin J. Curry, Patricia L. Brown, Michael B. Zemel, Leucine Modulates Mitochondrial Biogenesis and SIRT1-AMPK Signaling in C2C12 Myotubes, Journal of Nutrition and Metabolism, 2014, 2014, 1

    CrossRef

  30. 30
    Michael W. Van Dyke, Lysine Deacetylase (KDAC) Regulatory Pathways: an Alternative Approach to Selective Modulation, ChemMedChem, 2014, 9, 3
  31. 31
    Sebastian Höppner, Philippe Delahaut, Wilhelm Schänzer, Mario Thevis, Mass spectrometric studies on the in vivo metabolism and excretion of SIRT1 activating drugs in rat urine, dried blood spots, and plasma samples for doping control purposes, Journal of Pharmaceutical and Biomedical Analysis, 2014, 88, 649

    CrossRef

  32. 32
    Jacqueline A. Gleave, Peter D. Perri, Joanne E. Nash, Mitochondrial dysfunction in Parkinson’s disease: a possible target for neuroprotection, Frontiers in Biology, 2014, 9, 6, 489

    CrossRef

  33. 33
    Shu Wang, Naima Moustaid-Moussa, Lixia Chen, Huanbiao Mo, Anuradha Shastri, Rui Su, Priyanka Bapat, InSook Kwun, Chwan-Li Shen, Novel insights of dietary polyphenols and obesity, The Journal of Nutritional Biochemistry, 2014, 25, 1, 1

    CrossRef

  34. 34
    C. B. Newgard, J. E. Pessin, Recent Progress in Metabolic Signaling Pathways Regulating Aging and Life Span, The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 2014, 69, Suppl 1, S21

    CrossRef

  35. 35
    Philip Chiu-Tsun Tang, Yam-Fung Ng, Susan Ho, Michael Gyda, Shun-Wan Chan, Resveratrol and cardiovascular health – Promising therapeutic or hopeless illusion?, Pharmacological Research, 2014, 90, 88

    CrossRef

  36. 36
    Teng Ma, Meng-Shan Tan, Jin-Tai Yu, Lan Tan, Resveratrol as a Therapeutic Agent for Alzheimer’s Disease, BioMed Research International, 2014, 2014, 1

    CrossRef

  37. 37
    Jingbo Li, Chunyang Xie, Junli Zhuang, Hali Li, Ye Yao, Changgang Shao, Haiyang Wang, Resveratrol attenuates inflammation in the rat heart subjected to ischemia-reperfusion: Role of the TLR4/NF-κB signaling pathway, Molecular Medicine Reports, 2014,

    CrossRef

  38. 38
    Gerald Thiel, Oliver G. Rössler, Resveratrol stimulates AP-1-regulated gene transcription, Molecular Nutrition & Food Research, 2014, 58, 7
  39. 39
    R. Liu, Y. Zhong, X. Li, H. Chen, B. Jim, M.-M. Zhou, P. Y. Chuang, J. C. He, Role of Transcription Factor Acetylation in Diabetic Kidney Disease, Diabetes, 2014, 63, 7, 2440

    CrossRef

  40. 40
    Xiao-Ling Zhou, Jin-Jie Xu, Yan-Hong Ni, Xiao-Chun Chen, Hong-Xia Zhang, Xing-Mei Zhang, Wei-Juan Liu, Li-Li Luo, Yu-Cai Fu, SIRT1 activator (SRT1720) improves the follicle reserve and prolongs the ovarian lifespan of diet-induced obesity in female mice via activating SIRT1 and suppressing mTOR signaling, Journal of Ovarian Research, 2014, 7, 1

    CrossRef

  41. 41
    Chunxiao Guo, Brian Sinnott, Brenda Niu, Malcolm B. Lowry, Mary L. Fantacone, Adrian F. Gombart, Synergistic induction of human cathelicidin antimicrobial peptide gene expression by vitamin D and stilbenoids, Molecular Nutrition & Food Research, 2014, 58, 3
  42. 42
    Rafael de Cabo, Didac Carmona-Gutierrez, Michel Bernier, Michael N. Hall, Frank Madeo, The Search for Antiaging Interventions: From Elixirs to Fasting Regimens, Cell, 2014, 157, 7, 1515

    CrossRef

  43. 43
    Mar Quiñones, Marta Miguel, Amaya Aleixandre, Beneficial effects of polyphenols on cardiovascular disease, Pharmacological Research, 2013, 68, 1, 125

    CrossRef

  44. 44
    Christopher B. Newgard, Norman E. Sharpless, Coming of age: molecular drivers of aging and therapeutic opportunities, Journal of Clinical Investigation, 2013, 123, 3, 946

    CrossRef

  45. 45
    David Porquet, Gemma Casadesús, Sergi Bayod, Alberto Vicente, Anna M. Canudas, Jordi Vilaplana, Carme Pelegrí, Coral Sanfeliu, Antoni Camins, Mercè Pallàs, Jaume del Valle, Dietary resveratrol prevents Alzheimer’s markers and increases life span in SAMP8, AGE, 2013, 35, 5, 1851

    CrossRef

  46. 46
    Susanne Holzhauser, Anja Freiwald, Christoph Weise, Gerd Multhaup, Chung-Ting Han, Sascha Sauer, Discovery and Characterization of Protein-Modifying Natural Products by MALDI Mass Spectrometry Reveal Potent SIRT1 and p300 Inhibitors, Angewandte Chemie International Edition, 2013, 52, 19
  47. 47
    B. P. Hubbard, A. P. Gomes, H. Dai, J. Li, A. W. Case, T. Considine, T. V. Riera, J. E. Lee, S. Y. E, D. W. Lamming, B. L. Pentelute, E. R. Schuman, L. A. Stevens, A. J. Y. Ling, S. M. Armour, S. Michan, H. Zhao, Y. Jiang, S. M. Sweitzer, C. A. Blum, J. S. Disch, P. Y. Ng, K. T. Howitz, A. P. Rolo, Y. Hamuro, J. Moss, R. B. Perni, J. L. Ellis, G. P. Vlasuk, D. A. Sinclair, Evidence for a Common Mechanism of SIRT1 Regulation by Allosteric Activators, Science, 2013, 339, 6124, 1216

    CrossRef

  48. 48
    Ashraf Virmani, Luigi Pinto, Zbigniew Binienda, Syed Ali, Food, Nutrigenomics, and Neurodegeneration—Neuroprotection by What You Eat!, Molecular Neurobiology, 2013, 48, 2, 353

    CrossRef

  49. 49
    Anne L. Widlund, Joseph A. Baur, Ole Vang, mTOR: more targets of resveratrol?, Expert Reviews in Molecular Medicine, 2013, 15,

    CrossRef

  50. 50
    Laurent Mouchiroud, Riekelt H. Houtkooper, Johan Auwerx, NAD+metabolism: A therapeutic target for age-related metabolic disease, Critical Reviews in Biochemistry and Molecular Biology, 2013, 48, 4, 397

    CrossRef

  51. 51
    Aikaterini Argyropoulou, Nektarios Aligiannis, Ioannis P. Trougakos, Alexios-Leandros Skaltsounis, Natural compounds with anti-ageing activity, Natural Product Reports, 2013, 30, 11, 1412

    CrossRef

  52. 52
    Steven G Gray, Perspectives on epigenetic-based immune intervention for rheumatic diseases, Arthritis Research & Therapy, 2013, 15, 2, 207

    CrossRef

  53. 53
    Fanny L. Cherblanc, Robert W. M. Davidson, Paolo Di Fruscia, Nitipol Srimongkolpithak, Matthew J. Fuchter, Perspectives on natural product epigenetic modulators in chemical biology and medicine, Natural Product Reports, 2013, 30, 5, 605

    CrossRef

  54. 54
    Pénélope A. Andreux, Riekelt H. Houtkooper, Johan Auwerx, Pharmacological approaches to restore mitochondrial function, Nature Reviews Drug Discovery, 2013, 12, 6, 465

    CrossRef

  55. 55
    Andreas Leiherer, Axel Mündlein, Heinz Drexel, Phytochemicals and their impact on adipose tissue inflammation and diabetes, Vascular Pharmacology, 2013, 58, 1-2, 3

    CrossRef

  56. 56
    Fernando F. Anhê, Yves Desjardins, Geneviève Pilon, Stéphanie Dudonné, Maria Inés Genovese, Franco M. Lajolo, André Marette, Polyphenols and type 2 diabetes: A prospective review, PharmaNutrition, 2013, 1, 4, 105

    CrossRef

  57. 57
    H. Yuan, R. Marmorstein, Red Wine, Toast of the Town (Again), Science, 2013, 339, 6124, 1156

    CrossRef

  58. 58
    Shrestha Ghosh, Baohua Liu, Zhongjun Zhou, Resveratrol activates SIRT1 in a Lamin A-dependent manner, Cell Cycle, 2013, 12, 6, 872

    CrossRef

  59. 59
    Fumitaka Sato, Nicholas E. Martinez, Maira Shahid, John W. Rose, Noel G. Carlson, Ikuo Tsunoda, Resveratrol Exacerbates Both Autoimmune and Viral Models of Multiple Sclerosis, The American Journal of Pathology, 2013, 183, 5, 1390

    CrossRef

  60. 60
    Bin Wang, Jin Sun, Xianghui Li, Qingqing Zhou, Jing Bai, Yonghui Shi, Guowei Le, Resveratrol prevents suppression of regulatory T-cell production, oxidative stress, and inflammation of mice prone or resistant to high-fat diet–induced obesity, Nutrition Research, 2013, 33, 11, 971

    CrossRef

  61. 61
    E. Paul Cherniack, Bruce R. Troen, Resveratrol: Effects on Lipids and Cardiovascular Risk, Current Cardiovascular Risk Reports, 2013, 7, 1, 9

    CrossRef

  62. 62
    Susanne Holzhauser, Anja Freiwald, Christoph Weise, Gerd Multhaup, Chung-Ting Han, Sascha Sauer, Screening und Charakterisierung von Protein-modifizierenden Naturstoffen durch MALDI-Massenspektrometrie bringen starke SIRT1- und p300-Inhibitoren hervor, Angewandte Chemie, 2013, 125, 19
  63. 63
    Brian J. Morris, Seven sirtuins for seven deadly diseases ofaging, Free Radical Biology and Medicine, 2013, 56, 133

    CrossRef

  64. 64
    X. Li, SIRT1 and energy metabolism, Acta Biochimica et Biophysica Sinica, 2013, 45, 1, 51

    CrossRef

  65. 65
    Seon Rang Woo, Jae Gwang Byun, Yang Hyun Kim, Eun-Ran Park, Hyun-Yoo Joo, Miyong Yun, Hyun-Jin Shin, Su-Hyeon Kim, Yan Nan Shen, Jeong-Eun Park, Gil-Hong Park, Kee-Ho Lee, SIRT1 suppresses cellular accumulation of β-TrCP E3 ligase via protein degradation, Biochemical and Biophysical Research Communications, 2013, 441, 4, 831

    CrossRef

  66. 66
    Adrianna Z Herskovits, Leonard Guarente, Sirtuin deacetylases in neurodegenerative diseases of aging, Cell Research, 2013, 23, 6, 746

    CrossRef

  67. 67
    Tatsuya Mimura, Yuichi Kaji, Hidetaka Noma, Hideharu Funatsu, Shinseiro Okamoto, The role of SIRT1 in ocular aging, Experimental Eye Research, 2013, 116, 17

    CrossRef

  68. 68
    Hidetaka Ota, Masahiro Akishita, Hiroko Tani, Tomoki Tatefuji, Sumito Ogawa, Katsuya Iijima, Masato Eto, Takuji Shirasawa, Yasuyoshi Ouchi, trans-Resveratrol inGnetum gnemonProtects against Oxidative-Stress-Induced Endothelial Senescence, Journal of Natural Products, 2013, 76, 7, 1242

    CrossRef

  69. 69
    Hans Abromeit, Srinivasaraghaven Kannan, Wolfgang Sippl, Gerhard K. E. Scriba, A new nonpeptide substrate of human sirtuin in a capillary electrophoresis-based assay. Investigation of the binding mode by docking experiments, ELECTROPHORESIS, 2012, 33, 11
  70. 70
    László Bodai, J. Lawrence Marsh, A novel target for Huntington's disease: ERK at the crossroads of signaling, BioEssays, 2012, 34, 2
  71. 71
    José M Villalba, Rafael de Cabo, Francisco J Alcain, A patent review of sirtuin activators: an update, Expert Opinion on Therapeutic Patents, 2012, 22, 4, 355

    CrossRef

  72. 72
    Joseph A. Baur, Zoltan Ungvari, Robin K. Minor, David G. Le Couteur, Rafael de Cabo, Are sirtuins viable targets for improving healthspan and lifespan?, Nature Reviews Drug Discovery, 2012, 11, 6, 443

    CrossRef

  73. 73
    Kosta Steliou, Michael S. Boosalis, Susan P. Perrine, José Sangerman, Douglas V. Faller, Butyrate Histone Deacetylase Inhibitors, BioResearch Open Access, 2012, 1, 4, 192

    CrossRef

  74. 74
    Huige Li, Ning Xia, Ulrich Förstermann, Cardiovascular effects and molecular targets of resveratrol, Nitric Oxide, 2012, 26, 2, 102

    CrossRef

  75. 75
    Robert Feil, Mario F. Fraga, Epigenetics and the environment: emerging patterns and implications, Nature Reviews Genetics, 2012,

    CrossRef

  76. 76
    Jay H. Chung, Metabolic benefits of inhibiting cAMP-PDEs with resveratrol, Adipocyte, 2012, 1, 4, 256

    CrossRef

  77. 77
    Helena Schirmer, Talita Carneiro Brandão Pereira, Eduardo Pacheco Rico, Denis Broock Rosemberg, Carla Denise Bonan, Maurício Reis Bogo, André Arigony Souto, Modulatory effect of resveratrol on SIRT1, SIRT3, SIRT4, PGC1α and NAMPT gene expression profiles in wild-type adult zebrafish liver, Molecular Biology Reports, 2012, 39, 3, 3281

    CrossRef

  78. 78
    Gabriela Gutiérrez-Salmeán, Guillermo Ceballos-Reyes, Israel Ramírez-Sánchez, Obesity and metabolic syndrome: Future therapeutics based on novel molecular pathways, Clínica e Investigación en Arteriosclerosis, 2012, 24, 4, 204

    CrossRef

  79. 79
    Evi M. Mercken, Bethany A. Carboneau, Susan M. Krzysik-Walker, Rafael de Cabo, Of mice and men: The benefits of caloric restriction, exercise, and mimetics, Ageing Research Reviews, 2012, 11, 3, 390

    CrossRef

  80. 80
    Loukia Katsouri, Katrin Blondrath, Magdalena Sastre, Peroxisome proliferator-activated receptor-γ cofactors in neurodegeneration, IUBMB Life, 2012, 64, 12
  81. 81
    Hongwei Yao, Irfan Rahman, Perspectives on translational and therapeutic aspects of SIRT1 in inflammaging and senescence, Biochemical Pharmacology, 2012, 84, 10, 1332

    CrossRef

  82. 82
    Bin Shao, Mei Tang, Ziqiang Li, Rui Zhou, Yaqi Deng, Chunlai Nie, Zhu Yuan, Liangxue Zhou, Minghai Tang, Aiping Tong, Yuquan Wei, Proteomics analysis of human umbilical vein endothelial cells treated with resveratrol, Amino Acids, 2012, 43, 4, 1671

    CrossRef

  83. 83
    Wataru Ogawa, Tetsuya Hosooka, Red wine acts through a familiar drug target, Diabetology International, 2012, 3, 2, 65

    CrossRef

  84. 84
    Sung-Jun Park, Faiyaz Ahmad, Andrew Philp, Keith Baar, Tishan Williams, Haibin Luo, Hengming Ke, Holger Rehmann, Ronald Taussig, Alexandra L. Brown, Myung K. Kim, Michael A. Beaven, Alex B. Burgin, Vincent Manganiello, Jay H. Chung, Resveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP Phosphodiesterases, Cell, 2012, 148, 3, 421

    CrossRef

  85. 85
    Jay H. Chung, Vincent Manganiello, Jason R.B. Dyck, Resveratrol as a calorie restriction mimetic: therapeutic implications, Trends in Cell Biology, 2012, 22, 10, 546

    CrossRef

  86. 86
    Dipti V Tillu, Ohannes K Melemedjian, Marina N Asiedu, Ning Qu, Milena De Felice, Gregory Dussor, Theodore J Price, Resveratrol engages AMPK to attenuate ERK and mTOR signaling in sensory neurons and inhibits incision-induced acute and chronic pain, Molecular Pain, 2012, 8, 1, 5

    CrossRef

  87. 87
    Jean-Louis Gallis, Nizar Serhan, Henri Gin, Patrice Couzigou, Marie-Christine Beauvieux, Resveratrol plus ethanol counteract the ethanol-induced impairment of energy metabolism: 31P NMR study of ATP and sn-glycerol-3-phosphate on isolated and perfused rat liver, Pharmacological Research, 2012, 65, 3, 387

    CrossRef

  88. 88
    Ying Xu, Ling Nie, Yang-Guang Yin, Jian-Lin Tang, Ji-Yin Zhou, Dan-Dan Li, Shi-Wen Zhou, Resveratrol protects against hyperglycemia-induced oxidative damage to mitochondria by activating SIRT1 in rat mesangial cells, Toxicology and Applied Pharmacology, 2012, 259, 3, 395

    CrossRef

  89. 89
    Baohua Liu, Shrestha Ghosh, Xi Yang, Huiling Zheng, Xinguang Liu, Zimei Wang, Guoxiang Jin, Bojian Zheng, Brian K. Kennedy, Yousin Suh, Matt Kaeberlein, Karl Tryggvason, Zhongjun Zhou, Resveratrol Rescues SIRT1-Dependent Adult Stem Cell Decline and Alleviates Progeroid Features in Laminopathy-Based Progeria, Cell Metabolism, 2012, 16, 6, 738

    CrossRef

  90. 90
    Stéphane Quideau, Denis Deffieux, Laurent Pouységu, Resveratrol Still Has Something To Say about Aging!, Angewandte Chemie International Edition, 2012, 51, 28
  91. 91
    Stéphane Quideau, Denis Deffieux, Laurent Pouységu, Resveratrol: Die Geschichte geht weiter, Angewandte Chemie, 2012, 124, 28
  92. 92
    Irfan Rahman, Vuokko L. Kinnula, Vera Gorbunova, Hongwei Yao, SIRT1 as a therapeutic target in inflammaging of the pulmonary disease, Preventive Medicine, 2012, 54, S20

    CrossRef

  93. 93
    Nathan L. Price, Ana P. Gomes, Alvin J.Y. Ling, Filipe V. Duarte, Alejandro Martin-Montalvo, Brian J. North, Beamon Agarwal, Lan Ye, Giorgio Ramadori, Joao S. Teodoro, Basil P. Hubbard, Ana T. Varela, James G. Davis, Behzad Varamini, Angela Hafner, Ruin Moaddel, Anabela P. Rolo, Roberto Coppari, Carlos M. Palmeira, Rafael de Cabo, Joseph A. Baur, David A. Sinclair, SIRT1 Is Required for AMPK Activation and the Beneficial Effects of Resveratrol on Mitochondrial Function, Cell Metabolism, 2012, 15, 5, 675

    CrossRef

  94. 94
    José M. Villalba, Francisco J. Alcaín, Sirtuin activators and inhibitors, BioFactors, 2012, 38, 5
  95. 95
    Riekelt H. Houtkooper, Eija Pirinen, Johan Auwerx, Sirtuins as regulators of metabolism and healthspan, Nature Reviews Molecular Cell Biology, 2012,

    CrossRef

  96. 96
    Lev Osherovich, Still un-sirtuin, Science-Business eXchange, 2012, 5, 7

    CrossRef

  97. 97
    Andreas S. Madsen, Christian A. Olsen, Substrates for Efficient Fluorometric Screening Employing the NAD-Dependent Sirtuin 5 Lysine Deacylase (KDAC) Enzyme, Journal of Medicinal Chemistry, 2012, 55, 11, 5582

    CrossRef

  98. 98
    Min Young Kim, Eun Sil Kang, Sun Ah Ham, Jung Seok Hwang, Tae Sik Yoo, Hanna Lee, Kyung Shin Paek, Chankyu Park, Hoon Taek Lee, Jin-Hoi Kim, Chang Woo Han, Han Geuk Seo, The PPARδ-mediated inhibition of angiotensin II-induced premature senescence in human endothelial cells is SIRT1-dependent, Biochemical Pharmacology, 2012, 84, 12, 1627

    CrossRef

  99. 99
    Kangning Liu, Minhua Zhang, Guhan Nagappan, Alzheimer's Disease, 2012,

    CrossRef

  100. 100
    Steven G. Gray, Epigenetics in Human Disease, 2012,

    CrossRef

  101. 101
    Raimana Ho, Andreas Nievergelt, Claudia Simoes Pires, Muriel Cuendet, Bioactive Natural Products, 2012,

    CrossRef

  102. 102
    Camilla Burnett, Sara Valentini, Filipe Cabreiro, Martin Goss, Milán Somogyvári, Matthew D. Piper, Matthew Hoddinott, George L. Sutphin, Vid Leko, Joshua J. McElwee, Rafael P. Vazquez-Manrique, Anne-Marie Orfila, Daniel Ackerman, Catherine Au, Giovanna Vinti, Michèle Riesen, Ken Howard, Christian Neri, Antonio Bedalov, Matt Kaeberlein, Csaba Sőti, Linda Partridge, David Gems, Absence of effects of Sir2 overexpression on lifespan in C. elegans and Drosophila, Nature, 2011, 477, 7365, 482

    CrossRef

  103. 103
    Kilian Huber, Giulio Superti-Furga, After the grape rush: Sirtuins as epigenetic drug targets in neurodegenerative disorders, Bioorganic & Medicinal Chemistry, 2011, 19, 12, 3616

    CrossRef

  104. 104
    Silvie Timmers, Ellen Konings, Lena Bilet, Riekelt H. Houtkooper, Tineke van de Weijer, Gijs H. Goossens, Joris Hoeks, Sophie van der Krieken, Dongryeol Ryu, Sander Kersten, Esther Moonen-Kornips, Matthijs K.C. Hesselink, Iris Kunz, Vera B. Schrauwen-Hinderling, Ellen E. Blaak, Johan Auwerx, Patrick Schrauwen, Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans, Cell Metabolism, 2011, 14, 5, 612

    CrossRef

  105. 105
    Yi Fan, Martina Hense, Ronny Ludewig, Christin Weisgerber, Gerhard K.E. Scriba, Capillary electrophoresis-based sirtuin assay using non-peptide substrates, Journal of Pharmaceutical and Biomedical Analysis, 2011, 54, 4, 772

    CrossRef

  106. 106
    Kristin E. Dittenhafer-Reed, Jessica L. Feldman, John M. Denu, Catalysis and Mechanistic Insights into Sirtuin Activation, ChemBioChem, 2011, 12, 2
  107. 107
    Jan Lewerenz, Pamela Maher, Control of Redox State and Redox Signaling by Neural Antioxidant Systems, Antioxidants & Redox Signaling, 2011, 14, 8, 1449

    CrossRef

  108. 108
    P. Maher, R. Dargusch, L. Bodai, P. E. Gerard, J. M. Purcell, J. L. Marsh, ERK activation by the polyphenols fisetin and resveratrol provides neuroprotection in multiple models of Huntington's disease, Human Molecular Genetics, 2011, 20, 2, 261

    CrossRef

  109. 109
    Dipak K. Das, Subhendu Mukherjee, Diptarka Ray, Erratum to: Resveratrol and red wine, healthy heart and longevity, Heart Failure Reviews, 2011, 16, 4, 425

    CrossRef

  110. 110
    Vittorio Calabrese, Carolin Cornelius, Salvatore Cuzzocrea, Ivo Iavicoli, Enrico Rizzarelli, Edward J. Calabrese, Hormesis, cellular stress response and vitagenes as critical determinants in aging and longevity, Molecular Aspects of Medicine, 2011, 32, 4-6, 279

    CrossRef

  111. 111
    S. M. Nadtochiy, E. Redman, I. Rahman, P. S. Brookes, Lysine deacetylation in ischaemic preconditioning: the role of SIRT1, Cardiovascular Research, 2011, 89, 3, 643

    CrossRef

  112. 112
    Andrew Mendelsohn, James W. Larrick, Master Switch of Mitochondrial Biogenesis: A Clinical Target for Health Span Enhancement?, Rejuvenation Research, 2011, 14, 2, 223

    CrossRef

  113. 113
    Sergiy M. Nadtochiy, Emily K. Redman, Mediterranean diet and cardioprotection: The role of nitrite, polyunsaturated fatty acids, and polyphenols, Nutrition, 2011, 27, 7-8, 733

    CrossRef

  114. 114
    Tina Wenz, Mitochondria and PGC-1α in Aging and Age-Associated Diseases, Journal of Aging Research, 2011, 2011, 1

    CrossRef

  115. 115
    Paola Vigilanza, Katia Aquilano, Sara Baldelli, Giuseppe Rotilio, Maria Rosa Ciriolo, Modulation of intracellular glutathione affects adipogenesis in 3T3-L1 cells, Journal of Cellular Physiology, 2011, 226, 8
  116. 116
    Giulio Maria Pasinetti, Jun Wang, Philippe Marambaud, Mario Ferruzzi, Paul Gregor, Lindsay Alexis Knable, Lap Ho, Neuroprotective and metabolic effects of resveratrol: Therapeutic implications for Huntington's disease and other neurodegenerative disorders, Experimental Neurology, 2011, 232, 1, 1

    CrossRef

  117. 117
    Mary Miu Yee Waye, New insights into how adenovirus might lead to obesity: An oxidative stress theory, Free Radical Research, 2011, 45, 8, 880

    CrossRef

  118. 118
    Kahlilia C Morris, Hung Wen Lin, John W Thompson, Miguel A Perez-Pinzon, Pathways for ischemic cytoprotection: Role of sirtuins in caloric restriction, resveratrol, and ischemic preconditioning, Journal of Cerebral Blood Flow & Metabolism, 2011, 31, 4, 1003

    CrossRef

  119. 119
    Hyeog Kang, Jeong-Yong Suh, Young-Sang Jung, Jae-Won Jung, Myung K. Kim, Jay H. Chung, Peptide Switch Is Essential for Sirt1 Deacetylase Activity, Molecular Cell, 2011, 44, 2, 203

    CrossRef

  120. 120
    Stéphane Quideau, Denis Deffieux, Céline Douat-Casassus, Laurent Pouységu, Pflanzliche Polyphenole: chemische Eigenschaften, biologische Aktivität und Synthese, Angewandte Chemie, 2011, 123, 3
  121. 121
    Stéphane Quideau, Denis Deffieux, Céline Douat-Casassus, Laurent Pouységu, Plant Polyphenols: Chemical Properties, Biological Activities, and Synthesis, Angewandte Chemie International Edition, 2011, 50, 3
  122. 122
    E. Paul Cherniack, Polyphenols: Planting the seeds of treatment for the metabolic syndrome, Nutrition, 2011, 27, 6, 617

    CrossRef

  123. 123
    Takanobu Yamamoto, Junichi Sadoshima, Protection of the Heart Against Ischemia/Reperfusion by Silent Information Regulator 1, Trends in Cardiovascular Medicine, 2011, 21, 1, 27

    CrossRef

  124. 124
    Feng Zhang, Suping Wang, Li Gan, Peter S. Vosler, Yanqin Gao, Michael J. Zigmond, Jun Chen, Protective effects and mechanisms of sirtuins in the nervous system, Progress in Neurobiology, 2011, 95, 3, 373

    CrossRef

  125. 125
    Swati Dhar, Chindo Hicks, Anait S. Levenson, Resveratrol and prostate cancer: Promising role for microRNAs, Molecular Nutrition & Food Research, 2011, 55, 8
  126. 126
    My Björklund, Jeanette Roos, Vladimir Gogvadze, Maria Shoshan, Resveratrol induces SIRT1- and energy–stress-independent inhibition of tumor cell regrowth after low-dose platinum treatment, Cancer Chemotherapy and Pharmacology, 2011, 68, 6, 1459

    CrossRef

  127. 127
    Ahmad N. Al-Dissi, Lynn P. Weber, Resveratrol preserves cardiac function, but does not prevent endothelial dysfunction or pulmonary inflammation after environmental tobacco smoke exposure, Food and Chemical Toxicology, 2011, 49, 7, 1584

    CrossRef

  128. 128
    Xavier Palomer, Sirt1 actúa en asociación con PPARα para proteger el corazón de la hipertrofia, las alteraciones metabólicas y la inflamación, Clínica e Investigación en Arteriosclerosis, 2011, 23, 3, 144

    CrossRef

  129. 129
    Giorgio Ramadori, Teppei Fujikawa, Jason Anderson, Eric D. Berglund, Renata Frazao, Shaday Michán, Claudia R. Vianna, David A. Sinclair, Carol F. Elias, Roberto Coppari, SIRT1 Deacetylase in SF1 Neurons Protects against Metabolic Imbalance, Cell Metabolism, 2011, 14, 3, 301

    CrossRef

  130. 130
    Geunyeong Park, Joo-Won Jeong, Ja-Eun Kim, SIRT1 deficiency attenuates MPP+-induced apoptosis in dopaminergic cells, FEBS Letters, 2011, 585, 1
  131. 131
    Thaddeus T. Schug, Xiaoling Li, Sirtuin 1 in lipid metabolism and obesity, Annals of Medicine, 2011, 43, 3, 198

    CrossRef

  132. 132
    Matthew P. Gillum, Derek M. Erion, Gerald I. Shulman, Sirtuin-1 regulation of mammalian metabolism, Trends in Molecular Medicine, 2011, 17, 1, 8

    CrossRef

  133. 133
    E. Morselli, G. Marino, M. V. Bennetzen, T. Eisenberg, E. Megalou, S. Schroeder, S. Cabrera, P. Benit, P. Rustin, A. Criollo, O. Kepp, L. Galluzzi, S. Shen, S. A. Malik, M. C. Maiuri, Y. Horio, C. Lopez-Otin, J. S. Andersen, N. Tavernarakis, F. Madeo, G. Kroemer, Spermidine and resveratrol induce autophagy by distinct pathways converging on the acetylproteome, The Journal of Cell Biology, 2011, 192, 4, 615

    CrossRef

  134. 134
    Robin K. Minor, Joseph A. Baur, Ana P. Gomes, Theresa M. Ward, Anna Csiszar, Evi M. Mercken, Kotb Abdelmohsen, Yu-Kyong Shin, Carles Canto, Morten Scheibye-Knudsen, Melissa Krawczyk, Pablo M. Irusta, Alejandro Martín-Montalvo, Basil P. Hubbard, Yongqing Zhang, Elin Lehrmann, Alexa A. White, Nathan L. Price, William R. Swindell, Kevin J. Pearson, Kevin G. Becker, Vilhelm A. Bohr, Myriam Gorospe, Josephine M. Egan, Mark I. Talan, Johan Auwerx, Christoph H. Westphal, James L. Ellis, Zoltan Ungvari, George P. Vlasuk, Peter J. Elliott, David A. Sinclair, Rafael de Cabo, SRT1720 improves survival and healthspan of obese mice, Scientific Reports, 2011, 1,

    CrossRef

  135. 135
    Yi Hu, Jing Liu, Junfeng Wang, Qingsong Liu, The controversial links among calorie restriction, SIRT1, and resveratrol, Free Radical Biology and Medicine, 2011, 51, 2, 250

    CrossRef

  136. 136
    Debin Lan, Min Lu, Shweta Sharma, Pamela L. Mellon, Jerrold M. Olefsky, Nicholas J.G. Webster, Trans-resveratrol inhibits phosphorylation of Smad2/3 and represses FSHβ gene expression by a SirT1-independent pathway in LβT2 gonadotrope cells, Reproductive Toxicology, 2011, 32, 1, 85

    CrossRef

  137. 137
    Talita Carneiro Brandão Pereira, Eduardo Pacheco Rico, Denis Broock Rosemberg, Helena Schirmer, Renato Dutra Dias, André Arigony Souto, Carla Denise Bonan, Maurício Reis Bogo , Zebrafish as a Model Organism to Evaluate Drugs Potentially Able to Modulate Sirtuin Expression, Zebrafish, 2011, 8, 1, 9

    CrossRef

  138. 138
    Daniel L. Smith, Tim R. Nagy, David B. Allison, Calorie restriction: what recent results suggest for the future of ageing research, European Journal of Clinical Investigation, 2010, 40, 5
  139. 139
    Frank Madeo, Nektarios Tavernarakis, Guido Kroemer, Can autophagy promote longevity?, Nature Cell Biology, 2010, 12, 9, 842

    CrossRef

  140. 140
    Alexander Link, Francesc Balaguer, Ajay Goel, Cancer chemoprevention by dietary polyphenols: Promising role for epigenetics, Biochemical Pharmacology, 2010, 80, 12, 1771

    CrossRef

  141. 141
    Vittorio Calabrese, Carolin Cornelius, Albena T. Dinkova-Kostova, Edward J. Calabrese, Mark P. Mattson, Cellular Stress Responses, The Hormesis Paradigm, and Vitagenes: Novel Targets for Therapeutic Intervention in Neurodegenerative Disorders, Antioxidants & Redox Signaling, 2010, 13, 11, 1763

    CrossRef

  142. 142
    Christoph A. Schmitt, Elke H. Heiss, Verena M. Dirsch, Effect of resveratrol on endothelial cell function: Molecular mechanisms, BioFactors, 2010, 36, 5
  143. 143
    S. M. Davidson, Endothelial mitochondria and heart disease, Cardiovascular Research, 2010, 88, 1, 58

    CrossRef

  144. 144
    Ewen Callaway, GlaxoSmithKline strikes back over anti-ageing pills, Nature, 2010,

    CrossRef

  145. 145
    Charlie Schmidt, GSK/Sirtris compounds dogged by assay artifacts, Nature Biotechnology, 2010, 28, 3, 185

    CrossRef

  146. 146
    Lizzie Buchen, Health benefits of red-wine chemical unclear, Nature, 2010,

    CrossRef

  147. 147
    Laura MacPherson, Jason Matthews, Inhibition of aryl hydrocarbon receptor-dependent transcription by resveratrol or kaempferol is independent of estrogen receptor α expression in human breast cancer cells, Cancer Letters, 2010, 299, 2, 119

    CrossRef

  148. 148
    Charles A Lunn, Label-free screening assays: a strategy for finding better drug candidates, Future Medicinal Chemistry, 2010, 2, 11, 1703

    CrossRef

  149. 149
    Matt Kaeberlein, Lessons on longevity from budding yeast, Nature, 2010, 464, 7288, 513

    CrossRef

  150. 150
    Laurent Mouchiroud, Laurent Molin, Nicolas Dallière, Florence Solari, Life span extension by resveratrol, rapamycin, and metformin: The promise of dietary restriction mimetics for an healthy aging, BioFactors, 2010, 36, 5
  151. 151
    Yechun Wang, Hui Chen, Oliver Yu, Metabolic engineering of resveratrol and other longevity boosting compounds, BioFactors, 2010, 36, 5
  152. 152
    Riekelt H. Houtkooper, Robert W. Williams, Johan Auwerx, Metabolic Networks of Longevity, Cell, 2010, 142, 1, 9

    CrossRef

  153. 153
    News in brief, Nature Reviews Drug Discovery, 2010, 9, 3, 194

    CrossRef

  154. 154
    Elaine Y. Hsia, Michael L. Goodson, June X. Zou, Martin L. Privalsky, Hong-Wu Chen, Nuclear receptor coregulators as a new paradigm for therapeutic targeting, Advanced Drug Delivery Reviews, 2010, 62, 13, 1227

    CrossRef

  155. 155
    John E. Dominy, Yoonjin Lee, Zachary Gerhart-Hines, Pere Puigserver, Nutrient-dependent regulation of PGC-1α's acetylation state and metabolic function through the enzymatic activities of Sirt1/GCN5, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2010, 1804, 8, 1676

    CrossRef

  156. 156
    Gerd Wagner, Pharmaceutical Bioassays–Methods & Applications. By Shiqi Peng and Ming Zhao., ChemMedChem, 2010, 5, 6
  157. 157
    Barbara Calamini, Kiira Ratia, Michael G. Malkowski, Muriel Cuendet, John M. Pezzuto, Bernard D. Santarsiero, Andrew D. Mesecar, Pleiotropic mechanisms facilitated by resveratrol and its metabolites, Biochemical Journal, 2010, 429, 2, 273

    CrossRef

  158. 158
    Jianjun Bao, Michael N. Sack, Protein deacetylation by sirtuins: delineating a post-translational regulatory program responsive to nutrient and redox stressors, Cellular and Molecular Life Sciences, 2010, 67, 18, 3073

    CrossRef

  159. 159
    Sangwoon Chung, Hongwei Yao, Samuel Caito, Jae-woong Hwang, Gnanapragasam Arunachalam, Irfan Rahman, Regulation of SIRT1 in cellular functions: Role of polyphenols, Archives of Biochemistry and Biophysics, 2010, 501, 1, 79

    CrossRef

  160. 160
    Matt Kaeberlein, Resveratrol and rapamycin: are they anti-aging drugs?, BioEssays, 2010, 32, 2
  161. 161
    Dipak K. Das, Subhendu Mukherjee, Diptarka Ray, Resveratrol and red wine, healthy heart and longevity, Heart Failure Reviews, 2010, 15, 5, 467

    CrossRef

  162. 162
    Bor Luen Tang, Resveratrol is neuroprotective because it is not a direct activator of Sirt1—A hypothesis, Brain Research Bulletin, 2010, 81, 4-5, 359

    CrossRef

  163. 163
    Daniel Herranz, Maribel Muñoz-Martin, Marta Cañamero, Francisca Mulero, Barbara Martinez-Pastor, Oscar Fernandez-Capetillo, Manuel Serrano, Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer, Nature Communications, 2010, 1, 1, 1

    CrossRef

  164. 164
    Julie L Huber, Michael W McBurney, Peter S DiStefano, Thomas McDonagh, SIRT1-independent mechanisms of the putative sirtuin enzyme activators SRT1720 and SRT2183, Future Medicinal Chemistry, 2010, 2, 12, 1751

    CrossRef

  165. 165
    Daniel Herranz, Manuel Serrano, SIRT1: recent lessons from mouse models, Nature Reviews Cancer, 2010, 10, 12, 819

    CrossRef

  166. 166
    Shin-ichiro Imai, Leonard Guarente, Ten years of NAD-dependent SIR2 family deacetylases: implications for metabolic diseases, Trends in Pharmacological Sciences, 2010, 31, 5, 212

    CrossRef

  167. 167
    Stephen J. Ralph, Sara Rodríguez-Enríquez, Jiri Neuzil, Emma Saavedra, Rafael Moreno-Sánchez, The causes of cancer revisited: “Mitochondrial malignancy” and ROS-induced oncogenic transformation – Why mitochondria are targets for cancer therapy, Molecular Aspects of Medicine, 2010, 31, 2, 145

    CrossRef

  168. 168
    Kiroloss Hanna, Mira Ibrahim, Robert E. Leggett, Robert M. Levin, The Effect of Calcium on the Response of Rabbit Urinar Bladder Muscle and Mucosa to Hydrogen Peroxide, Urological Science, 2010, 21, 4, 175

    CrossRef

  169. 169
    Cynthia J. Kenyon, The genetics of ageing, Nature, 2010, 464, 7288, 504

    CrossRef

  170. 170
    Heather B. Patisaul, Wendy Jefferson, The pros and cons of phytoestrogens, Frontiers in Neuroendocrinology, 2010, 31, 4, 400

    CrossRef

  171. 171
    Ian A. Clark, Lisa M. Alleva, Bryce Vissel, The roles of TNF in brain dysfunction and disease, Pharmacology & Therapeutics, 2010, 128, 3, 519

    CrossRef

  172. 172
    Aneta Balcerczyk, Luciano Pirola, Therapeutic potential of activators and inhibitors of sirtuins, BioFactors, 2010, 36, 5
  173. 173
    Doug Auld, Anton Simeonov, Craig Thomas, Literature Search and Review, ASSAY and Drug Development Technologies, 2009, 7, 6, 544

    CrossRef

  174. 174
    Daniel M. Fass, Melissa M. Kemp, Frederick A. Schroeder, Florence F. Wagner, Qiu Wang, Edward B. Holson, Histone Acetylation and Deacetylation, Reviews in Cell Biology and Molecular Medicine,